Sarcoma & GIST
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
Conference Coverage
Largest meeting on cancer research canceled: AACR
From the Journals
Late effects in young cancer survivors underscore importance of high-risk screening
Childhood cancer survivors have higher standardized mortality ratios than early-adolescent and young adult cancer survivors.
News
FDA: Cell phones still look safe
The available evidence does not suggest a causal link between cell phone use and cancer, according to the FDA.
From the Journals
CRISPR-engineered T cells may be safe for cancer, but do they work?
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
From the Journals
Global project reveals cancer’s genomic playbook
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.
Article
Presentation of a Rare Malignancy: Leiomyosarcoma of the Prostate
Prostatic leiomyosarcoma is an aggressive malignancy with a high risk of metastasis and a poor prognosis that poses unique diagnostic and...
News
FDA approves first treatment for advanced epithelioid sarcoma
Tazemetostat earns accelerated approval for the treatment of patients aged 16 years and older with metastatic or locally advanced epithelioid...